Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $242,150 - $336,271
-3,340 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$90.24 - $124.05 $12,633 - $17,367
-140 Reduced 4.02%
3,340 $319,000
Q2 2021

Aug 03, 2021

SELL
$93.66 - $139.27 $31,750 - $47,212
-339 Reduced 8.88%
3,480 $433,000
Q4 2020

Jan 22, 2021

BUY
$99.61 - $142.12 $13,945 - $19,896
140 Added 3.81%
3,819 $506,000
Q3 2020

Oct 16, 2020

SELL
$72.92 - $102.01 $24,792 - $34,683
-340 Reduced 8.46%
3,679 $375,000
Q2 2020

Jul 15, 2020

SELL
$55.75 - $92.75 $19,791 - $32,926
-355 Reduced 8.12%
4,019 $349,000
Q1 2020

Apr 28, 2020

BUY
$37.9 - $104.44 $11,370 - $31,332
300 Added 7.36%
4,374 $254,000
Q4 2018

Feb 08, 2019

SELL
$56.04 - $82.66 $22,416 - $33,064
-400 Reduced 8.94%
4,074 $257,000
Q3 2018

Oct 29, 2018

SELL
$48.29 - $80.6 $20,088 - $33,529
-416 Reduced 8.51%
4,474 $353,000
Q2 2018

Aug 07, 2018

BUY
$37.84 - $69.96 $185,037 - $342,104
4,890 New
4,890 $292,000
Q1 2018

Apr 24, 2018

SELL
$39.82 - $57.53 $194,719 - $281,321
-4,890 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$46.49 - $60.51 $227,336 - $295,893
4,890
4,890 $244,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fluent Financial, LLC Portfolio

Follow Fluent Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fluent Financial, LLC with notifications on news.